Chemoinformaics analysis of indole-3-acetic-acid
| Molecular Weight | 179.175 | nRot | 3 |
| Heavy Atom Molecular Weight | 170.103 | nRig | 13 |
| Exact Molecular Weight | 179.058 | nRing | 1 |
| Solubility: LogS | -3.164 | nHRing | 0 |
| Solubility: LogP | 2.067 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 24.5371 |
| nHD | 2 | BPOL | 11.3349 |
| QED | 0.656 |
| Synth | 3.62 |
| Natural Product Likeliness | 1.56 |
| NR-PPAR-gamma | 0.042 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.034 |
| HIA | 0.013 |
| CACO-2 | -4.723 |
| MDCK | 0.0000182 |
| BBB | 0.341 |
| PPB | 0.796757 |
| VDSS | 1.325 |
| FU | 0.188861 |
| CYP1A2-inh | 0.35 |
| CYP1A2-sub | 0.919 |
| CYP2c19-inh | 0.115 |
| CYP2c19-sub | 0.714 |
| CYP2c9-inh | 0.044 |
| CYP2c9-sub | 0.601 |
| CYP2d6-inh | 0.036 |
| CYP2d6-sub | 0.631 |
| CYP3a4-inh | 0.042 |
| CYP3a4-sub | 0.307 |
| CL | 10.349 |
| T12 | 0.363 |
| hERG | 0.023 |
| Ames | 0.592 |
| ROA | 0.112 |
| SkinSen | 0.063 |
| Carcinogencity | 0.862 |
| EI | 0.036 |
| Respiratory | 0.299 |
| NR-Aromatase | 0.791 |
| Antiviral | No |
| Prediction | 0.876886 |